Trending Now
The NCCN Recommends CTI BioPharma Corp’s (NASDAQ: CTIC) VONJO for Myeloproliferative...
CTI BioPharma Corp's (NASDAQ: CTIC) VONJO is now recommended to treat myeloproliferative neoplasms in the National Comprehensive Cancer Network (NCCN)
According to Dr Adam R....
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Adial Pharmaceuticals Inc. (NASDAQ:ADIL) Receives Approval For ONWARD Study, To Use...
Adial Pharmaceuticals Inc. (NASDAQ:ADIL) has announced that its breakthrough ONWARD pivotal third phase clinical study in Poland has received approval for the evaluation of...
MAKE IT MODERN
LATEST REVIEWS
Cardlytics Inc (CDLX) surge is justified with its updated guidance
Cardlytics Inc (CDLX) opened today at $4.80, significantly higher than its previous close of $3.45. During the trading session, the bid price...
MAKE IT MODERN
PERFORMANCE TRAINING
Humanigen Inc.’s (NASDAQ: HGEN) Emergency Use Authorization Application For Lenzilumab In COVID-19 Declined
Humanigen Inc. (NASDAQ: HGEN) has announced that the FDA has declined its Emergency Use Authorization application for lenzilumab in treating newly hospitalized coronavirus patients.
FDA...
Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) Announces Q3 2021 Financial Results And Updates On Expansion...
Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) has announced financial results for the quarter ending September 30, 2021, and offered a business update.
Corvus ended Q3 2021...
ObsEva SA (NASDAQ:OBSV) Publishes Results Of Pilot Linzagolix Study In Treatment Of Adenomyosis
ObsEva SA (NASDAQ:OBSV) has announced a publication in the Fertility and Sterility Journal of “Gonadotropin-releasing Hormone Antagonist (linzagolix): a New Therapy for uterine adenomyosis.”...
Altimmune Inc. (NASDAQ: ALT) Announces Promising First Phase Pemvidutide Study Results In Obese Individuals
Altimmune Inc. (NASDAQ: ALT) has released encouraging results from the twelve-week first phase study of pemvidutide. Pemvidutide is an experimental glucagon-like peptide-1 glucagon double...
Sanofi SA (NASDAQ:SNY) And Translate Bio Inc (NASDAQ:TBIO) Report High Antibody Count Triggered By...
Sanofi SA (NASDAQ:SNY) and Translate Bio Inc (NASDAQ:TBIO) released the preliminary findings of their preclinical trials evaluating an mRNA-based coronavirus vaccine candidate called MRT5500.
The...
MAKE IT MODERN
